A PYMNTS Company

US/EU: Actavis inks 7-nation pharma sale

By  |  January 20, 2014

US-based pharmaceutical company Actavis announced last Friday it inked a deal to make divestitures across seven different nations in the EU, say reports, though the company did not disclose financial details of the sales.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The company announced plans to sell its generic operations to Aurobindo Pharma, based in India. The businesses span across France, the Netherlands, Italy, Germany, Portugal, Spain and Belgium and would include pharmaceutical products, marketing and dossier license rights.

    The deal, which remains subject to regulatory clearance in various jurisdictions, includes plans for Actavis to operate the units as usual until the transaction is complete.

    Full Content: MenaFN

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.